Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 14 Colorectal Neoplasms 6 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Biliary Tract Neoplasms 3 Recurrence 2 Nasopharyngeal Carcinoma 2 Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Non-resectable 1 Pancreatic Cancer Metastatic to Liver 1 Pancreatic Adenocarcinoma 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Neoadjuvant Chemotherapy 1 Metastatic Pancreatic Adenocarcinoma 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Efficacy and Safety 1

Interventions

Gemcitabine 5 Albumin-Bound Paclitaxel 4 Taxes 3 Fluorouracil 3 dehydroftorafur 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Oxaliplatin 2 130-nm albumin-bound paclitaxel 2 irinotecan sucrosofate 1 indusatumab 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Radiotherapy, Image-Guided 1 Pancreatectomy 1 Losartan 1 Leucovorin 1 Irinotecan 1 Folfox protocol 1 Cetuximab 1 Anesthesia, General 1 Anesthesia 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡